Status:
UNKNOWN
A Modified Lateral Lumbar Interbody Fusion VS. Transforaminal Lumbar Interbody Fusion for Adult Degenerative Scoliosis
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborating Sponsors:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
First Affiliated Hospital of Shantou University Medical College
Conditions:
Degenerative Scoliosis
Minimally Invasive
Eligibility:
All Genders
50-75 years
Phase:
NA
Brief Summary
A modified lateral lumbar interbody fusion VS. transforaminal lumbar interbody fusion for the treatment of adult degenerative scoliosis with 2 year follow-up with a multiple center, randomized case-co...
Detailed Description
Adult degenerative scoliosis (ADS) is the most common spinal deformity in the elderly, and the severe patients need surgical treatment. The elderly are often complicated with many medical diseases and...
Eligibility Criteria
Inclusion
- at least 50 years of age, diagnosed with adult thoracolumbar scoliosis including any number of intervertebral levels between T8 and S1, unresponsive to conservative treatment for at least 6 months, and had a preoperative coronal Cobb angle of at least 10° and preoperative ODI score of at least 30%.
Exclusion
- with prior lumbar fusion surgery or spondylolisthesis greater than Grade II
Key Trial Info
Start Date :
May 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT04071665
Start Date
May 1 2020
End Date
December 31 2022
Last Update
May 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Second Affiliated Hospital, School of Medicine, Zejiang University
Hangzhou, Zhejiang, China, 310000